AF
FLNA

Allworth Financial’s Filana Therapeutics FLNA Stock Holding History

Allworth Financial’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-185
Closed -$539 – 5255
2025
Q3 		$539 Buy
+185
New +$425 ﹤0.01% 4415
2023
Q4 		– Sell
-58
Closed -$966 – 3600
2023
Q3 		$966 Buy
+58
New +$1.15K ﹤0.01% 2863
2023
Q2 		– Sell
-19
Closed -$459 – 3366
2023
Q1 		$459 Buy
+19
New +$526 ﹤0.01% 2858
2022
Q4 		– Sell
-242
Closed -$10K – 3170
2022
Q3 		$10K Buy
+242
New +$6.54K ﹤0.01% 1675

Other funds holding FLNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Allworth Financial's FLNA Position: Q4 2025 in Review

Allworth Financial sold out of Filana Therapeutics (FLNA) in Q4 2025, closing a stake of 185 shares — an estimated $539 sold.

Allworth Financial first reported a position in FLNA in Q3 2022 and held it in 4 quarters. The position peaked at $10K in Q3 2022. 107 funds tracked by Wall St. Rank hold FLNA as of Q4 2025.

  • Allworth Financial reported no remaining Filana Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Allworth Financial sold 185 Filana Therapeutics shares in Q4 2025, an estimated $539.
  • Allworth Financial first reported a position in Filana Therapeutics in Q3 2022 and held it in 4 quarters.
  • Allworth Financial's Filana Therapeutics position peaked at $10K in Q3 2022.
  • 107 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2025.

Based on Allworth Financial's 13F filing for Q4 2025, filed 5 Feb 2026.